首页|COVID-19是多重耐药菌感染/定植的危险因素吗?——COVID-19大流行期间一项住院患者多重耐药菌感染调查

COVID-19是多重耐药菌感染/定植的危险因素吗?——COVID-19大流行期间一项住院患者多重耐药菌感染调查

扫码查看
目的 医院大规模收治新型冠状病毒感染(COVID-19)患者的状况下,分析COVID-19是否为住院患者多重耐药菌(MDRO)感染/定植的潜在危险因素。方法 回顾性分析2022年12月1日-2023年1月31日某三级甲等医院的住院患者资料。比较COVID-19患者与非COVID-19患者的临床资料、抗菌药物治疗情况、MDRO检出情况。将检出病原菌的患者分为MDRO组和非MDRO组,采用多因素logistic回归分析住院患者MDRO感染/定植的危险因素。结果 收治各类住院患者共16 710例,其中COVID-19组2 403例,8。83%(113/1 280)检出 MDRO;非 COVID-19 组 14 307 例,4。43%(167/3 770)检出 MDRO。COVID-19 组患者耐碳青霉烯类肺炎克雷伯菌(CRKP)检出率高于非COVID-19组(48。15%VS 30。89%,P=0。028)。多因素分析结果显示,危重患者(OR=4。796,95%CI:3。524~6。527)、培养前接受抗菌药物治疗≥2 d(OR=2。330,95%CI:1。699~3。196)、培养出真菌(OR=1。780,95%CI:1。318~2。405)、住院日数长(OR=1。036,95%CI:1。030~1。042)是住院患者MDRO感染/定植的危险因素(均P<0。05)。结论 医院大规模收治COVID-19患者期间,MDRO感染/定植与是否为危重患者、抗菌药物使用、培养出真菌、住院日数长有关,COVID-19不是MDRO感染/定植的危险因素。
Is COVID-19 a risk factor for infection/colonization with multidrug-re-sistant organisms?A survey on multidrug-resistant organisms infection in hospitalized patients during the COVID-19 pandemic
Objective To analyze whether coronavirus disease 2019(COVID-19)is a potential risk for the infec-tion/colonization with multidrug-resistant organisms(MDROs)in hospitalized patients during a surge admission of COVID-19 patients.Methods Data of hospitalized patients in a tertiary first-class hospital from December 1,2022 to January 31,2023 were retrospectively analyzed.Clinical data,antimicrobial therapy,and MDROs detection re-sult between COVID-19 patients and non-COVID-19 patients were compared.Patients with detected pathogens were divided into MDRO group and non-MDRO group.Risk factors for infection/colonization with MDROs in hos-pitalized patients were analyzed by multivariate logistic regression.Results A total of 16 710 patients were admitted in hospital,2 403 cases were in COVID-19 group,and 8.83%(113/1 280)were MDRO-infected cases;14 307 ca-ses were in non-COVID-19 group,and 4.43%(167/3 770)were MDRO-infected cases.The detection rate of car-bapenem-resistant Klebsiella pneumoniae(CRKP)in patients in COVID-19 group was higher than that in non-CO-VID-19 group(48.15%vs 30.89%,P=0.028).Multivariate analysis results showed that critical illness(OR=4.796,95%CI:3.524-6.527),antimicrobial therapy≥2days before pathogen culture(OR=2.330,95%CI:1.699-3.196),positive fungi culture(OR=1.780,95%CI:1.318-2.405),long hospital stay(OR=1.036,95%CI:1.030-1.042)were risk factors for MDRO infection/colonization in hospitalized patients(all P<0.05).Conclusion During mass admission of COVID-19 patients,MDROs infection/colonization is related to critical ill-ness,antimicrobial use,positive fungi culture and long hospital stay,while COVID-19 infection is not a risk factor for MDROs infection/colonization.

COVID-19co-infectionantimicrobial therapymultidrug-resistant organism

叶永康、周子筌、覃金爱

展开 >

广西医科大学第一附属医院医院感染管理科,广西南宁 530021

新型冠状病毒感染 合并感染 抗菌药物治疗 多重耐药菌

2024

中国感染控制杂志
中南大学

中国感染控制杂志

CSTPCD北大核心
影响因子:2.112
ISSN:1671-9638
年,卷(期):2024.23(10)